Concordia Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CONCORDIA PHARMS INC
CONCORDIA PHARMS INC has two approved drugs.
Summary for Concordia Pharms Inc
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Concordia Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concordia Pharms Inc | ORAPRED | prednisolone sodium phosphate | SOLUTION;ORAL | 075117-001 | Dec 14, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Concordia Pharms Inc | KAPVAY | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022331-003 | Sep 28, 2010 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Concordia Pharms Inc | JENLOGA | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022331-002 | May 25, 2010 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Concordia Pharms Inc | KAPVAY | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022331-004 | Sep 28, 2010 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Concordia Pharms Inc | JENLOGA | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022331-001 | Sep 30, 2009 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Concordia Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Concordia Pharms Inc | JENLOGA | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022331-001 | Sep 30, 2009 | 5,869,100 | ⤷ Start Trial |
| Concordia Pharms Inc | KAPVAY | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022331-003 | Sep 28, 2010 | 5,869,100 | ⤷ Start Trial |
| Concordia Pharms Inc | KAPVAY | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022331-004 | Sep 28, 2010 | 5,869,100 | ⤷ Start Trial |
| Concordia Pharms Inc | JENLOGA | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022331-002 | May 25, 2010 | 5,869,100 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for CONCORDIA PHARMS INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Tablets | 0.1 mg and 0.2 mg | ➤ Subscribe | 2011-03-04 |
| ➤ Subscribe | Orally Disintegrating Tablets | 10 mg, 15 mg and 30 mg | ➤ Subscribe | 2010-07-22 |
| ➤ Subscribe | Extended-release Tablets | 0.1 mg and 0.2 mg | ➤ Subscribe | 2011-03-04 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
